ArticleFrontiers in immunology2025

Ribosome biogenesis-related gene signature predicts prognosis and immune landscape in glioma and identifies UTP20 as a therapeutic target.

Yadan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.